What Paige AI Pathology does
Paige AI assists pathologists in detecting prostate cancer in tissue biopsies with FDA-cleared AI algorithms. The system flags suspicious regions for pathologist review, reducing missed cancers and improving diagnostic accuracy.
Paige AI Pathology is a healthcare tool on Falcoscan. FDA-cleared AI for prostate cancer pathology detection. Falcoscan rates Paige AI Pathology with an Opportunity score of 86/100, a Saturation score of 8/100, and a Wrapper-risk score of 11/100. Market signal: stable. Paige AI Pathology is founded in 2017, currently at Series_a stage. Pricing: Paid. Falcoscan rating 4.7/5.